The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Value Trend Is Expected For The Infectious Disease Molecular Diagnostics Market From 2026 To 2030?
The infectious disease molecular diagnostics market size has demonstrated strong growth in recent years. It is projected to expand from $30.46 billion in 2025 to $32.04 billion in 2026, at a compound annual growth rate (CAGR) of 5.2%. Historically, this growth is attributable to factors such as the increasing prevalence of infectious diseases, advancements in PCR and sequencing technologies, rising government funding for infectious disease research, greater awareness about early diagnosis, and the expansion of clinical laboratories.
The infectious disease molecular diagnostics market size is projected to experience consistent expansion over the upcoming years. It is expected to reach $38.77 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.9%. This anticipated growth can be attributed to factors such as the increasing integration of AI-powered diagnostic instruments, a heightened need for swift and precise diagnostic methods, the development of healthcare infrastructure in emerging markets, a greater emphasis on individualized medical treatments, and the proliferation of molecular diagnostic solutions for home use. Key trends during this period are expected to include the widespread adoption of quick point-of-care diagnostics, an increasing requirement for multiplex assays, the incorporation of molecular diagnostics into electronic health record (EHR) systems, the broadening scope of infectious disease monitoring initiatives, and a sharpened focus on identifying antimicrobial resistance.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25793&type=smp
What Market Drivers Are Helping Shape The Infectious Disease Molecular Diagnostics Market Expansion?
The infectious disease molecular diagnostics market is projected to expand due to the growing occurrence of infectious diseases. These diseases are conditions resulting from disease-causing microorganisms like bacteria, viruses, fungi, or parasites, which can transmit between individuals directly or indirectly. The rising incidence of these illnesses is largely attributable to globalization and increased travel, facilitating the swift spread of pathogens across regions and transforming local outbreaks into worldwide health crises. Infectious disease molecular diagnostics aid in managing these conditions by offering quick, precise pathogen detection at the genetic level, which assists in early detection, focused therapies, and successful outbreak containment. As an illustration, the US Centers for Disease Control and Prevention (CDC), a US-based government agency, reported in November 2024 that tuberculosis (TB) cases in 2023 reached 9,633, an increase from 8,332 in 2022, signifying a 15.6% rise in cases. Consequently, the increasing prevalence of infectious diseases is fueling the expansion of the infectious disease molecular diagnostics market.
What Key Segment Areas Are Included In The Infectious Disease Molecular Diagnostics Market Assessment?
The infectious disease molecular diagnostics market covered in this report is segmented –
1) By Product Type: Kits And Reagents, Instruments, Software And Services
2) By Technology: Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Sequencing-Based Molecular Diagnostics, Transcription Mediated Amplification, Other Technologies
3) By Application: Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications
4) By End-User: Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes
Subsegments:
1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits
2) By Instruments: Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers
3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services
Which Trends Are Shaping The Infectious Disease Molecular Diagnostics Market Landscape?
Major companies engaged in the infectious disease molecular diagnostics market are concentrating on developing innovative solutions, such as real-time polymerase chain reaction kits, to enable the rapid, accurate, and high-throughput identification of infectious pathogens. Real-time polymerase chain reaction (PCR) kits function as diagnostic instruments that amplify and simultaneously detect specific genetic material of pathogens in real time, thereby allowing for quick and precise identification of infectious diseases. For instance, in February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences company, launched Applied Biosystems TaqPath polymerase chain reaction kits designed for detecting infectious diseases in India. These kits are fast, highly sensitive multiplex diagnostic solutions that facilitate real-time polymerase chain reaction detection of infectious disease targets using a complete workflow, from ribonucleic acid extraction to diagnostic report generation, typically in under 4 hours. Key features of these kits include multiplexed assays that target multiple genomic regions of pathogens, the incorporation of internal process controls, and automated data interpretation, which collectively reduce user error and enhance result reliability.
Which Companies Form The Competitive Landscape Of The Infectious Disease Molecular Diagnostics Market?
Major companies operating in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.
Access The Complete Infectious Disease Molecular Diagnostics Market Report:
Which Region Has The Strongest Presence In The Infectious Disease Molecular Diagnostics Market?
North America was the largest region in the infectious disease molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Infectious Disease Molecular Diagnostics Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Infectious Disease Molecular Diagnostics Market 2026, By The Business Research Company
Infection Control Market Report 2026
https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report
Infection Prevention Market Report 2026
https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report
Hospital Acquired Infection Control Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model